Better Therapeutics, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Dec 2023)

FII

3.72%

Held by 6 FIIs

DII

94.28%

Held by 2 DIIs

Promoter

0.00%

How big is Better Therapeutics, Inc.?

22-Jun-2025

As of Jun 18, Better Therapeutics, Inc. has a market capitalization of 0.01, classifying it as a Micro Cap company, with net sales of 0.00 million and a net profit of -31.58 million over the last four quarters. As of Dec'22, the company reported shareholder's funds of -0.90 million and total assets of 22.94 million.

Is Better Therapeutics, Inc. technically bullish or bearish?

20-Sep-2025

As of April 1, 2024, Better Therapeutics, Inc. shows a mildly bearish trend despite a recent 100% return over the past month, with long-term performance concerning at -99.99% over three years compared to the S&P 500's 70.41%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.78

Return on Equity

-999,999.00%

Price to Book

-0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2023)

Net Profit:

-6 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

0.0%

2 Years

-99.95%

3 Years

-99.99%

4 Years

-100.0%

5 Years

0.0%

Better Therapeutics, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Better Therapeutics, Inc. technically bullish or bearish?

As of 1 April 2024, the technical trend for Better Therapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the weekly MACD indicating a bearish trend and the daily moving averages also showing a mildly bearish position. The monthly MACD and KST are mildly bullish, but the overall sentiment remains cautious due to the bearish monthly RSI. In terms of performance, the stock has returned 100% over the past week and month, significantly outperforming the S&P 500, which returned 1.05% and 2.33% respectively. However, the long-term view is concerning, with a -99.99% return over the past three years compared to the S&P 500's 70.41%....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

-2.13

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.78

Sales to Capital Employed (avg)

0.00

Tax Ratio

2.45%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.31%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-0.00

EV to EBIT

-0.20

EV to EBITDA

-0.22

EV to Capital Employed

-3.46

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 5 Schemes (2.0%)

Foreign Institutions

Held by 6 Foreign Institutions (3.72%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2023 is 48.25% vs -5,600.00% in Sep 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'23",
        "Sep'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.50",
          "val2": "-10.30",
          "chgp": "56.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.40",
          "chgp": "25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.90",
          "val2": "-11.40",
          "chgp": "48.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 1.24% vs -529.69% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-35.50",
          "val2": "-28.90",
          "chgp": "-22.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "0.20",
          "chgp": "650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-9.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-39.80",
          "val2": "-40.30",
          "chgp": "1.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY

Sep'23

Sep'22

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-4.50

-10.30

56.31%

Interest

0.50

0.40

25.00%

Exceptional Items

0.00

Consolidate Net Profit

-5.90

-11.40

48.25%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2023 is 0.00% vs 0.00% in Sep 2022

Consolidated Net Profit

YoY Growth in quarter ended Sep 2023 is 48.25% vs -5,600.00% in Sep 2022

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'22

Dec'22

Dec'21

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-35.50

-28.90

-22.84%

Interest

1.50

0.20

650.00%

Exceptional Items

0.00

-9.70

100.00%

Consolidate Net Profit

-39.80

-40.30

1.24%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2022 is 0.00% vs 0.00% in Dec 2021

Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 1.24% vs -529.69% in Dec 2021

All Annual Results

Company CV

About Better Therapeutics, Inc.

Better Therapeutics, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Better Therapeutics, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Better Therapeutics, Inc.?

Watch in Real-Time

Is Better Therapeutics, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Better Therapeutics, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'23 - YoY

Annual Results Snapshot (Consolidated) - Dec'22

About Better Therapeutics, Inc.

Company Coordinates